Growth Metrics

Avanos Medical (AVNS) Cash from Discontinued Operations (2018)

Avanos Medical recorded quarterly Cash from Discontinued Operations of 89900000.0 in Q2 2018.

Avanos Medical's Cash from Discontinued Operations history runs 1 years deep, the most recent figure standing at 89900000.0 for Q2 2018.

  • In Q2 2018, Cash from Discontinued Operations changed N/A year-over-year to 89900000.0; the TTM figure through Sep 2019 stood at 89900000.0 (changed 0.0% YoY), while the FY2018 annual figure was 98400000.0, changed N/A from the prior year.
  • Cash from Discontinued Operations came in at 89900000.0 for Q2 2018 at Avanos Medical.
  • In the past five years, Cash from Discontinued Operations ranged from a high of 89900000.0 in Q2 2018 to a low of 89900000.0 in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Avanos Medical 1.17 Bn 1.10 Bn 94.20 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2018 89.90 Mn
Jun 30, 2018 89.90 Mn